Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Organon & Co. Director's Dealing 2024

May 7, 2024

31461_dirs_2024-05-07_4c37aab9-179f-4641-a66f-0cc64d4c51a1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Organon & Co. (OGN)
CIK: 0001821825
Period of Report: 2024-05-04

Reporting Person: Stahler Rachel A (Chief Information Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-05-04 Common Stock M 3049 Acquired 49282 Direct
2024-05-04 Common Stock F 1045 $19.61 Disposed 48237 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-05-04 Restricted Stock Units $ M 3049 Disposed Common Stock (3049) Direct

Footnotes

F1: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU.

F2: On each of May 4, 2022, May 4, 2023 and May 4, 2024, one-third of the RSUs vested.